Journal article
Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice
Jennifer A Westwood, Phillip K Darcy, Preethi Mayura Guru, Janelle Sharkey, Hollie J Pegram, Sally M Amos, Mark J Smyth, Michael H Kershaw
Journal of Translational Medicine | BMC | Published : 2010
Grants
Funding Acknowledgements
This work was supported by grants from The National Health and Medical Research Council of Australia (NHMRC), The Cancer Council of Australia, The Bob Parker Memorial Trust and the Peter MacCallum Cancer Centre Foundation. M.K. is supported by a NHMRC Senior Research Fellowship. P.D. is supported by a NHMRC Career Development Award, and M.S. is supported by an Australia Fellowship from the NHMRC.